Latest Ratios: P/E Ratio -75.9x · EV/EBITDA N/A · ROE -248.8%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $193M | $243M | $96M | — | — | — | — |
| Enterprise Value | $195M | $245M | $99M | — | — | — | — |
| P/E Ratio → | -75.90 | — | — | — | — | — | — |
| P/S Ratio | 9.03 | 11.36 | 5.28 | — | — | — | — |
| P/B Ratio | 24.67 | 32.83 | 14.68 | — | — | — | — |
| P/FCF | 70.89 | 89.19 | — | — | — | — | — |
| P/OCF | 66.76 | 83.99 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 11.44 | 5.46 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | 89.83 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 33.1% | 33.1% | 36.1% | 32.3% | 31.2% | 30.1% | 46.7% |
| Operating Margin | -79.6% | -79.6% | -8.6% | 12.9% | 8.0% | 14.0% | 31.1% |
| Net Profit Margin | -80.9% | -80.9% | -10.6% | 13.9% | 8.2% | 13.5% | 23.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | -248.8% | -248.8% | -31.4% | 50.0% | 29.0% | 71.3% | 108.5% |
| ROA | -81.5% | -81.5% | -10.9% | 18.0% | 9.9% | 23.8% | 29.4% |
| ROIC | -134.4% | -134.4% | -15.6% | 33.0% | 15.6% | 40.4% | 81.2% |
| ROCE | -210.3% | -210.3% | -24.4% | 45.7% | 28.2% | 73.4% | 141.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.83 | 0.83 | 0.99 | 0.35 | 0.72 | 0.43 | 0.47 |
| Debt / EBITDA | — | — | — | 0.83 | 2.40 | 0.79 | 0.32 |
| Net Debt / Equity | — | 0.24 | 0.51 | -0.13 | 0.34 | 0.40 | 0.31 |
| Net Debt / EBITDA | — | — | — | -0.30 | 1.13 | 0.75 | 0.21 |
| Debt / FCF | — | 0.64 | — | -0.39 | — | — | — |
| Interest Coverage | -143.27 | -143.27 | -13.71 | 36.86 | 19.55 | 47.32 | 89.34 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | 1.32 | 1.10 | 1.34 | 1.30 | 1.30 | 1.04 |
| Quick Ratio | 1.24 | 1.24 | 1.00 | 1.28 | 1.27 | 1.19 | 0.90 |
| Cash Ratio | 0.34 | 0.34 | 0.24 | 0.30 | 0.19 | 0.02 | 0.06 |
| Asset Turnover | — | 0.96 | 0.90 | 1.11 | 1.05 | 1.29 | 1.24 |
| Inventory Turnover | 13.00 | 13.00 | 8.75 | 21.36 | 36.73 | 13.12 | 6.74 |
| Days Sales Outstanding | — | 170.49 | 198.84 | 189.95 | 195.68 | 186.13 | 134.37 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | 1.4% | 1.1% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $24M | $20M | $21M | $21M | $21M | $21M |
Imminent liquidity and solvency
Based on reported figures, HUHU trades at a price-to-sales multiple of 11.61, which appears disconnected from the company's negative earnings profile and suggests that market participants are pricing the equity based on speculative domestic substitution narratives rather than current fundamental performance or tangible cash flow generation.
The absence of a positive P/E ratio and the elevated P/S multiple indicate that investors are paying a premium for potential future growth that has yet to materialize in the bottom line. This valuation level warrants caution, as it implies a high expectation for rapid scale that the current cost structure and project-based revenue volatility may struggle to support.
As reported in financial statements, HUHU's ROIC plummeted to -9.1% in 2025Q4, reflecting a significant decay in the efficiency of invested capital compared to the positive returns observed in 2023, which suggests that the firm is currently destroying shareholder value through its aggressive, loss-making expansion strategy.
The sharp reversal from positive ROIC in 2023 to double-digit negative figures indicates that the company's capital-intensive investments are not yielding the expected operational returns. This trend suggests that management's current allocation of capital is failing to generate sufficient margins to cover the cost of the underlying infrastructure.
According to recent SEC filings, HUHU's cash conversion cycle reached 279 days in 2025Q4, a dramatic deterioration from the 36-day cycle seen in 2023Q4, which highlights severe inefficiencies in managing receivables and inventory that are directly impeding the company's ability to convert project-based revenue into usable cash.
The ballooning DSO to 623 days suggests that the company is struggling to collect payments from its semiconductor and pharmaceutical clients, effectively financing its customers at the expense of its own liquidity. This structural inefficiency in working capital management appears to be a primary driver of the firm's ongoing cash burn.
Based on HUHU's reported figures, the debt-to-equity ratio has climbed to 0.83 in 2025Q4, indicating that the company is increasingly relying on debt to bridge the gap between its project-based revenue cycles and the high fixed costs inherent in its specialized industrial manufacturing operations.
While the current leverage level remains moderate, the negative interest coverage ratio of -156.81 suggests that the company is not generating sufficient operating income to service its debt obligations comfortably. Investors should monitor whether this reliance on debt leads to further balance sheet strain if revenue volatility persists.
As indicated by the provided financial data, the price-to-sales ratio is a commonly misapplied metric for HUHU, as it obscures the company's severe operating losses and the high probability that current revenue recognition is not translating into actual cash inflows due to extended collection cycles.
Analysts should prioritize cash-flow-based metrics or break-even revenue analysis over P/S multiples, as the latter fails to account for the significant SG&A overhang and the capital intensity of the business. Relying on revenue multiples in this context may lead to a dangerous underestimation of the firm's liquidity risk.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HUHU stock.
HUHUTECH International Group Inc. Ordinary Shares's current P/E ratio is -75.9x. This places it at the 50th percentile of its historical range.
HUHUTECH International Group Inc. Ordinary Shares's return on equity (ROE) is -248.8%. The historical average is -3.6%.
Based on historical data, HUHUTECH International Group Inc. Ordinary Shares is trading at a P/E of -75.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
HUHUTECH International Group Inc. Ordinary Shares has 33.1% gross margin and -79.6% operating margin.